Literature DB >> 27042495

Predicting Healthcare Utilization by Patients Admitted for COPD Exacerbation.

Karthikeyan Ramaraju1, Anupama Murthy Kaza2, Nithilavalli Balasubramanian3, Siddhuraj Chandrasekaran4.   

Abstract

BACKGROUND: Healthcare utilization, especially length of hospital stay and ICU admission, for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) determine overall outcomes in terms of morbidity, mortality and cost burden. Predicting prolonged hospital stay (PHS) and prolonged intensive care (PIC) for AECOPD is useful for rational allocation of resources in healthcare centres. AIM: To characterize the pattern of healthcare utilization by COPD patients hospitalized for acute exacerbation, and to identify clinical and laboratory predictors of 'prolonged hospital stay' (PHS) and 'prolonged intensive care'(PIC).
MATERIALS AND METHODS: This study attempted through retrospective data analysis, to identify risk factors and evolve prediction models for increased healthcare utilization namely PHS and PIC for AECOPD. The data were extracted from 255 eligible admissions for AECOPD by 166 patients from Aug 2012 to July 2013. Logistic regression analysis was used for identifying predictors and models were tested with area under receiver operating characteristic curve.
RESULTS: Independent predictors of prolonged hospital stay (≥ 6 days) were chronic respiratory failure at baseline, low saturation at admission, high HbA1c level and positive isolates in sputum culture. Independent predictors of prolonged intensive care (for ≥ 48 hours) were past history of pulmonary tuberculosis, chronic respiratory failure at baseline, low saturation at admission, high leukocyte count and positive culture isolates in sputum. Prediction models evolved from variables available at admission showed AUC 0.805 (95% CI 0.729 - 0.881) and 0.825 (95% CI 0.75 - 0.90) for PHS and ICU admissions respectively.
CONCLUSION: Our prediction models derived from simple and easily available variables show good discriminative properties in predicting PHS and PIC for AECOPD. When prospectively validated, these models are useful for rational allocation of services especially in resource limited settings.

Entities:  

Keywords:  Intensive care; Length of hospital stay

Year:  2016        PMID: 27042495      PMCID: PMC4800561          DOI: 10.7860/JCDR/2016/17721.7216

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Incidence and causes of non-invasive mechanical ventilation failure after initial success.

Authors:  M Moretti; C Cilione; A Tampieri; C Fracchia; A Marchioni; S Nava
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

Authors:  A F Connors; N V Dawson; C Thomas; F E Harrell; N Desbiens; W J Fulkerson; P Kussin; P Bellamy; L Goldman; W A Knaus
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

3.  Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong.

Authors:  Fanny W S Ko; Tony K C Ng; Thomas S T Li; Joan P C Fok; Michael C H Chan; Alan K L Wu; David S C Hui
Journal:  Respir Med       Date:  2005-04       Impact factor: 3.415

4.  Resource use and risk factors in high-cost exacerbations of COPD.

Authors:  Jan B Oostenbrink; Maureen P M H Rutten-van Mölken
Journal:  Respir Med       Date:  2004-09       Impact factor: 3.415

5.  Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  M G Seneff; D P Wagner; R P Wagner; J E Zimmerman; W A Knaus
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

6.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

7.  Derivation of a prognostic equation to predict in-hospital mortality and requirement of invasive mechanical ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  A Mohan; S P Bhatt; C Mohan; S Arora; T K Luqman-Arafath; R Guleria
Journal:  Indian J Chest Dis Allied Sci       Date:  2008 Oct-Dec

8.  The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.

Authors:  N Mittmann; L Kuramoto; S J Seung; J M Haddon; C Bradley-Kennedy; J M Fitzgerald
Journal:  Respir Med       Date:  2007-12-20       Impact factor: 3.415

9.  Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit.

Authors:  Alladi Mohan; Raya Premanand; Lebaka Narayana Reddy; Mangu H Rao; Surendra K Sharma; Ranjit Kamity; Srinivas Bollineni
Journal:  BMC Pulm Med       Date:  2006-12-19       Impact factor: 3.317

10.  Evaluation of oxygen prescription in relation to hospital admission rate in patients with chronic obstructive pulmonary disease.

Authors:  Alice M Turner; Sourav Sen; Cathryn Steeley; Yasmin Khan; Pamela Sweeney; Yvonne Richards; Rahul Mukherjee
Journal:  BMC Pulm Med       Date:  2014-08-05       Impact factor: 3.317

View more
  2 in total

Review 1.  Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.

Authors:  Valerie G Press; R Tamara Konetzka; Steven R White
Journal:  Curr Opin Pulm Med       Date:  2018-03       Impact factor: 3.155

2.  Utility of Computed Tomography in a Differential Diagnosis for the Patients with an Initial Diagnosis of Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Hyung Jun Park; Soo Han Kim; Ho Cheol Kim; Bo Young Lee; Sei Won Lee; Jae Seung Lee; Sang Do Lee; Joon Beom Seo; Yeon Mok Oh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.